Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition. | Chem Sci | 2022 | 35308862 | PubTator, text mining | PubMed |
| Chemical Labeling and Enrichment of Histone Glyoxal Adducts. | ACS Chem Biol | 2022 | 35294181 | PubTator, text mining | PubMed |
| Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future. | Ther Adv Endocrinol Metab | 2022 | 35281302 | PubTator, text mining | PubMed |
| Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review. | Saudi J Biol Sci | 2022 | 35280538 | PubTator, text mining | PubMed |
| Combination of Stem Cells with Chinese Herbs for Secondary Depression in Neurodegenerative Diseases Based on Traditional Chinese Medicine Theories. | Evid Based Complement Alternat Med | 2022 | 35280507 | PubTator, text mining | PubMed |
| Involvement of osmoregulation, glyoxalase, and non-glyoxalase systems in signaling molecule glutamic acid-boosted thermotolerance in maize seedlings. | Protoplasma | 2022 | 35277781 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors. | Int J Mol Sci | 2022 | 35269594 | PubTator, text mining | PubMed |
| Lactylation: a Passing Fad or the Future of Posttranslational Modification. | Inflammation | 2022 | 35224683 | PubTator, text mining | PubMed |
| Methylglyoxal detoxification pathway - Explored first time for imazethapyr tolerance in lentil (Lens culinaris L.). | Plant Physiol Biochem | 2022 | 35219898 | PubTator, text mining | PubMed |
| Hexokinase-2-Linked Glycolytic Overload and Unscheduled Glycolysis-Driver of Insulin Resistance and Development of Vascular Complications of Diabetes. | Int J Mol Sci | 2022 | 35216280 | PubTator, text mining | PubMed |
| Uncovering a Hub Signaling Pathway of Antimicrobial-Antifungal-Anticancer Peptides' Axis on Short Cationic Peptides via Network Pharmacology Study. | Int J Mol Sci | 2022 | 35216171 | PubTator, text mining | PubMed |
| Pathogenic Molecular Mechanisms in Periodontitis and Peri-Implantitis: Role of Advanced Glycation End Products. | Life (Basel) | 2022 | 35207505 | PubTator, text mining | PubMed |
| Reactive Oxygen Species Differentially Modulate the Metabolic and Transcriptomic Response of Endothelial Cells. | Antioxidants (Basel) | 2022 | 35204316 | PubTator, text mining | PubMed |
| Curcumin: Biological Activities and Modern Pharmaceutical Forms. | Antibiotics (Basel) | 2022 | 35203738 | PubTator, text mining | PubMed |
| Pyramiding of γ-TMT and gly I transgenes in Brassica juncea enhances salinity and drought stress tolerance. | Physiol Plant | 2022 | 35199363 | PubTator, text mining | PubMed |
| Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma. | Nat Commun | 2022 | 35197447 | PubTator, text mining | PubMed |
| Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer. | Sci Rep | 2022 | 35194111 | PubTator, text mining | PubMed |
| Regulation of zinc-dependent enzymes by metal carrier proteins. | Biometals | 2022 | 35192096 | PubTator, text mining | PubMed |
| Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection. | Molecules | 2022 | 35164003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=22